Project Number 1R43AG071337-01A1 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Discovery of 12/15-lipoxygenase inhibitors to suppress neuroinflammation and slow disease progression in Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) f. Inflammation Researcher and Organization Principal Investigator SHRADER, WILLIAM DVORAK Principal Investigator First Name WILLIAM DVORAK Principal Investigator Last Name SHRADER Awardee Organization ACUREX THERAPEUTICS CORPORATION Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $450,060 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
